https://www.prittleprattlenews.com/melange/bridge-biotherapeutics-announces-the-initiation-of-the-proof-of-mechanism-study-for-bbt-401-in-patients-with-ulcerative-colitis-rectal-delivery-of-drug-to-target-site/
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site